We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.69%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.2B
AUM Growth
+$1.14B
(+8.1%)
Cap. Flow
+$754M
Cap. Flow
% of AUM
4.96%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
1,269
New
352
Increased
317
Reduced
269
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$124M |
| 2 |
Texas Instruments
TXN
|
+$113M |
| 3 |
UnitedHealth
UNH
|
+$106M |
| 4 |
Philip Morris
PM
|
+$106M |
| 5 |
TJX Companies
TJX
|
+$93.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$240M |
| 2 |
Zoetis
ZTS
|
+$221M |
| 3 |
Constellation Brands
STZ
|
+$123M |
| 4 |
Moody's
MCO
|
+$112M |
| 5 |
Estee Lauder
EL
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.99% |
| 2 | Consumer Discretionary | 12.3% |
| 3 | Technology | 11.57% |
| 4 | Communication Services | 10.98% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vulcan Materials
VMC
$36.3B
| $98.8M | 0.65% |
789,581
+291,459
| +59% | +$35.3M |
|
27
Dentsply Sirona
XRAY
$2.59B
| $98.2M | 0.65% |
1,700,940
+697,037
| +69% | +$41.2M |
|
28
Incyte
INCY
$23.5B
| $94.3M | 0.62% |
940,303
+196,129
| +26% | +$19.1M |
|
29
Applied Materials
AMAT
$426B
| $93.3M | 0.61% |
2,891,352
+2,858,659
| +8,744% | +$87M |
|
30
PTC
PTC
$13.7B
| $88.3M | 0.58% |
1,908,300
+352,787
| +23% | +$16.5M |
|
31
Allison Transmission
ALSN
$10.1B
| $88.1M | 0.58% |
2,615,455
+1,532,879
| +142% | +$47.7M |
|
|
SYT
32
DELISTED
Syngenta Ag
SYT
| $85.7M | 0.56% |
1,084,677
+562,250
| +108% | +$45.3M |
|
33
DuPont de Nemours
DD
$18.6B
| $85.4M | 0.56% |
589,029
+512,036
| +665% | +$71.3M |
|
34
Quest Diagnostics
DGX
$25.1B
| $85.3M | 0.56% |
928,386
+5,266
| +0.6% | +$454K |
|
|
WOOF
35
DELISTED
VCA Inc.
WOOF
| $85.2M | 0.56% |
1,241,291
+1,052,831
| +559% | +$68.7M |
|
36
LyondellBasell Industries
LYB
$19.5B
| $85.1M | 0.56% |
991,640
-608,049
| -38% | -$51M |
|
|
ANDV
37
DELISTED
Andeavor
ANDV
| $81.1M | 0.53% |
927,183
+483,548
| +109% | +$41M |
|
|
OPLN
38
Openlane
OPLN
$4.17B
| $80.8M | 0.53% |
5,007,618
+3,107,320
| +164% | +$49.6M |
|
|
TMX
39
DELISTED
Terminix Global Holdings, Inc.
TMX
| $79.7M | 0.52% |
3,157,123
+684,316
| +28% | +$16.8M |
|
40
Boston Scientific
BSX
$65.8B
| $79.5M | 0.52% |
3,673,296
-2,018,968
| -35% | -$44.1M |
|
41
KLA
KLAC
$275B
| $77.1M | 0.51% |
9,803,470
-534,290
| -5% | -$4.08M |
|
|
GXP
42
DELISTED
Great Plains Energy Incorporated
GXP
| $74.7M | 0.49% |
2,731,528
+225,537
| +9% | +$6.16M |
|
43
Sherwin-Williams
SHW
$78.3B
| $72.7M | 0.48% |
811,353
-392,880
| -33% | -$34.7M |
|
44
Zimmer Biomet
ZBH
$17.7B
| $72M | 0.47% |
718,569
+228,690
| +47% | +$24.5M |
|
45
AutoZone
AZO
$48.3B
| $71.5M | 0.47% |
90,472
-71,203
| -44% | -$54.8M |
|
46
Advanced Micro Devices
AMD
$851B
| $71.3M | 0.47% |
6,289,058
-4,156,166
| -40% | -$34.9M |
|
|
PRAH
47
DELISTED
PRA Health Sciences, Inc.
PRAH
| $69.2M | 0.46% |
1,256,101
+401,341
| +47% | +$22M |
|
|
DFS
48
DELISTED
Discover Financial Services
DFS
| $68.4M | 0.45% |
948,972
+293,567
| +45% | +$18.7M |
|
|
GCP
49
DELISTED
GCP Applied Technologies Inc.
GCP
| $68.1M | 0.45% |
2,544,115
-682,682
| -21% | -$18.5M |
|
50
Regions Financial
RF
$26.3B
| $67.8M | 0.45% |
4,723,761
+1,579,041
| +50% | +$19.5M |
|
Similar funds
Marshall Wace's Q4 2016 Portfolio in Review
As of Q4 2016, Marshall Wace held 1,269 positions worth $15.2B, up 8.1% from $14.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $754M of net new capital in Q4 2016, opening 352 new positions and adding to 317 existing holdings. Its largest new stake was Texas Instruments: 1,581,130 shares worth $115M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Zoetis, an estimated $221M trimmed.
- Marshall Wace's largest Q4 2016 buy was Texas Instruments: 1,581,130 shares worth $115M.
- Marshall Wace added most to Amazon in Q4 2016, an estimated $124M increase.
- Marshall Wace's biggest Q4 2016 reduction was Zoetis, cutting an estimated $221M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q4 2016, selling an estimated $240M.
- Marshall Wace's ten largest holdings make up 16% of its $15.2B portfolio in Q4 2016.
- Marshall Wace opened 352 new positions and closed 320 in Q4 2016.
- Marshall Wace's portfolio value rose 8.1% quarter-over-quarter to $15.2B.
Based on Marshall Wace's 13F filing for Q4 2016, filed 10 Feb 2017.